- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Cancer Metastatic in New Zealand
Total 8601 results
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Memorial Sloan Kettering Cancer CenterDuke UniversityCompleted
-
Hoffmann-La RocheCompleted
-
Neovii BiotechFresenius Biotech North AmericaTerminatedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Solid Carcinoma | HER2-negative Breast Cancer | MEK1 Gene Mutation | MEK2 Gene MutationUnited States
-
University of VirginiaSyndax PharmaceuticalsCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
SanofiCompletedBreast Cancer MetastaticIndia
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany
-
National Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
Alaunos TherapeuticsMemorial Sloan Kettering Cancer CenterUnknownMetastatic Breast CancerUnited States
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
The Cooper Health SystemCompletedCancer | Metastatic CancerUnited States
-
SCRI Development Innovations, LLCDaiichi Sankyo, Inc.RecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast CarcinomaUnited States
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy...CompletedMetastatic Breast CancerAustralia
-
Hoffmann-La RocheCompletedHER2-Positive Metastatic Breast Cancer | HER2-Negative Metastatic Breast Cancer | Locally Advanced or Early Breast CancerUnited States
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Dawn L. HershmanNational Cancer Institute (NCI); Incyte CorporationCompletedMetastatic Breast Cancer | Breast Carcinoma | HER-2 Positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedMetastatic or Locally-advanced Unresectable Breast CancerUnited States
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesCompleted
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCRecruitingMetastatic Breast Cancer | Brain MetastasesUnited States
-
University of RochesterCompletedBreast Cancer, MetastaticUnited States
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHormone Receptor Positive Metastatic Breast CancerUnited States
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Janssen Diagnostics, LLCCompletedMetastatic Breast CancerUnited States, Canada
-
Max SungTerminatedBreast Cancer | Metastatic CancerUnited States
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast CarcinomaUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCCelgeneCompletedMetastatic Breast CancerUnited States
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
Tracon Pharmaceuticals Inc.United States Department of Defense; Roswell Park Cancer InstituteCompletedMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
Roswell Park Cancer InstituteRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast CarcinomaUnited States
-
SCRI Development Innovations, LLCEli Lilly and Company; AmgenCompletedMetastatic Breast CancerUnited States
-
Fox Chase Cancer CenterPfizer; National Comprehensive Cancer NetworkCompletedMetastatic Breast CancerUnited States
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
Memorial Sloan Kettering Cancer CenterCompletedOsseous Lesions From Metastatic Breast CancerUnited States
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research FoundationRecruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States